Características clínicas y respuesta a la fototerapia de los pacientes con psoriasis
Resumen
La psoriasis es una enfermedad inflamatoria crónica que afecta entre el 1 y el 3 % de la población mundial, asociada a enfermedades como el síndrome metabólico y la enfermedad coronaria, entre otras, que repercute en la calidad de vida de los pacientes.
Referencias bibliográficas
Hsu LN, Armstrong AW. Psoriasis and autoimmune disorders: A review of the literature. J Am Acad Dermatol. 2012;67:1076-9.
https://doi.org/10.1016/j.jaad.2012.01.029
Wu JJ, Nguyen TU, Poon K-YT, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67:924-30.
https://doi.org/10.1016/j.jaad.2012.04.039
Wolf N, Quaranta M, Prescott NJ, Allen M, Smith R, Burden AD, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45:114-6.
https://doi.org/10.1136/jmg.2007.053595
Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol. 2007;87:506-9.
https://doi.org/10.2340/00015555-0297
Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: An opportunity to identify cardiovascular risk. Br J Dermatol. 2009;160:1-7.
https://doi.org/10.1111/j.1365-2133.2008.08874.x
Chandran V. The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol. 2012;44:149- 56.
https://doi.org/10.1007/s12016-012-8303-5
Wohlrab J, Fiedler G, Gerdes S, Nast A, Philipp S, Radtke MA, et al. Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res. 2013;305:91-8.
https://doi.org/10.1007/s00403-013-1318-9
Christophers E. Psoriasis- epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314- 20.
https://doi.org/10.1046/j.1365-2230.2001.00832.x
Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377-85.
https://doi.org/10.1038/jid.2012.339
González C, Castro LA, De La Cruz G, Arenas CM, Beltrán A, Santos AM. Caracterización epidemiológica de la psoriasis en el Hospital Militar Central. Asoc Col Dermatol. 2008;17:11-7.
Vélez N, Bohórquez L, Corrales MF, Orrego S, Jiménez SB, Zuluaga Á, et al. Caracterización de los pacientes con psoriasis en tratamiento con fototerapia. Rev Asoc Colomb Dermatol. 2011;19:100-6. Fecha de consulta: 1° de abril de 2016. Disponible en: http://bdigital.ces.edu.co:8080/repositorio/ handle/10946/3690.
González G. Pabón Y, Meza N. Factores de riesgo cardiovascular en docentes universitarios. Memorias 2012;10:129-36.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68:654-62.
https://doi.org/10.1016/j.jaad.2012.08.015
Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies. J Hypertens. 2013;31:433-42.
https://doi.org/10.1097/HJH.0b013e32835bcce1
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis. JAMA Dermatol. 2013;149:84.
https://doi.org/10.1001/2013.jamadermatol.406
Nisa N, Qazi M. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:662.
https://doi.org/10.4103/0378-6323.72462
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-41.
https://doi.org/10.1001/jama.296.14.1735
Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: Population based cohort study. BMJ. 2013;347:f5961.
https://doi.org/10.1136/bmj.f5961
Ahlehoff O, Gislason GH, Jorgensen CH, Lindhardsen J, Charlot M, Olesen JB, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: A Danish Nationwide Cohort Study. Eur Heart J. 2012;33:2054-64.
https://doi.org/10.1093/eurheartj/ehr285
Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: A systematic review and meta-analysis. Br J Dermatol. 2014;170:304-14.
https://doi.org/10.1111/bjd.12670
Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, et al. Psoriasis and smoking: A systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. J Cutan Med Surg. 2016;20:221-7.
https://doi.org/10.1177/1203475415616073
Ma C, Harskamp CT, Armstrong EJ, Armstrong AW. The association between psoriasis and dyslipidaemia: A systematic review. Br J Dermatol. 2013;168:486-95.
https://doi.org/10.1111/bjd.12101
Pietrzak A, Kądzielewski J, Janowski K, Roliński J, Krasowska D, Chodorowska G, et al. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. Int J Dermatol. 2009;48:379-87.
https://doi.org/10.1111/j.1365-4632.2009.03994.x
Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin. 2015;33:41-55.
https://doi.org/10.1016/j.det.2014.09.004
González C, Londoño A, Castro L. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Bogotá: Asociación Colombiana de Dermatología y Cirugía Dermatológica; 2012.
Powell JB, Gach JE. Phototherapy in the elderly. Clin Exp Dermatol. 2015;40:605-10.
https://doi.org/10.1111/ced.12626
Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. Psoriasis therapy and cardiovascular risk factors: A 12-week follow-up study. Am J Clin Dermatol. 2010;11:423-32.
https://doi.org/10.2165/11319310-000000000-00000
Romaní J, Caixàs A, Carrascosa JM, Ribera M, Rigla M, Luelmo J. Effect of narrow band ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis. Br J Dermatol. 2012;166:1237-44.
https://doi.org/10.1111/j.1365-2133.2012.10883.x
Prodanowich S, Ma F, Taylor J, Pezon C, Fasihi T, Kirsner R. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol. 2005;52:262-7.
https://doi.org/10.1016/j.jaad.2004.06.017
Gisondi P, Ferrazzi A, Girolomoni G. Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat. 2010;18:297-304.
Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. Coeliac disease associated with psoriasis. Br J Dermatol. 2009;161:1331-4.
https://doi.org/10.1111/j.1365-2133.2009.09398.x
Patiño-Villada FA, Arango-Vélez EF, Quintero-Velásquez MA, Arenas-Sosa MM. Factores de riesgo cardiovascular en una población urbana de Colombia. Rev Salud Pública (Bogotá). 2011;13:433- 45.
Phan C, Sigal ML, Lhafa M, Barthélémy H, Maccari F, Estève E, et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol. 2016;143:264-74.
https://doi.org/10.1016/j.annder.2015.06.024
Espinoza CJ, Lacy RM, Soto ME, Kresch NS, VegaMemije ME. Prevalencia del síndrome metabólico en pacientes con psoriasis. Gac Med Mex. 2014;150:311-6.
Takahashi H, Takahashi I, Honma M, Ishida-Yamamoto A, Iizuka H. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci. 2010;57:143-4.
https://doi.org/10.1016/j.jdermsci.2009.11.002
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.
https://doi.org/10.1007/s00403-006-0703-z
Zindancı I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, et al. Prevalence of metabolic syndrome in patients with psoriasis. Scientific World Journal. 2012;2012:312463.
https://doi.org/10.1100/2012/312463
Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of MetabolicSyndrome in Patientswith Psoriasis: A Population-BasedStudy in theUnitedKingdom. J InvestDermatol. 2012 Mar;132(3):556-62.
https://doi.org/10.1038/jid.2011.365
Brenaut E, Horreau C, Pouplard C, Barnetche T, Paul C, Richard M-A, et al. Alcohol consumption and psoriasis: a systematicliteraturereview. J EurAcadDermatolVenereol. 2013 Aug;27:30-5.
https://doi.org/10.1111/jdv.12164
Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2:e54.
https://doi.org/10.1038/nutd.2012.26
Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 2013;14:87-109.
https://doi.org/10.1007/s40257-013-0015-y
Sokolova A, Lee A, D Smith S. The safety and efficacy of narrow band ultraviolet B treatment in dermatology: A review. Am J Clin Dermatol. 2015;16:501-31.
https://doi.org/10.1007/s40257-015-0151-7
Vañó-Galván S, Gárate MT, Fleta-Asín B, Hidalgo á., Fernández-Guarino M, Bermejo T, et al. Análisis coste-efectividad de la fototerapia domiciliaria con ultravioleta B de banda estrecha frente a fármacos biológicos en el tratamiento de la psoriasis moderada-grave. Actas Dermosifiliogr. 2012;103:127-37.
https://doi.org/10.1016/j.ad.2011.05.002
Disponible en: https://www.minsalud.gov.co/Documents/General/Cifras-tabaco-Colombia.pdf.
Descargas
